Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 2
2011 3
2012 3
2013 3
2014 5
2015 5
2016 8
2017 11
2018 1
2019 8
2020 6
2021 4
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL Jr, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. Boorjian SA, et al. Among authors: alemozaffar m. Lancet Oncol. 2021 Jan;22(1):107-117. doi: 10.1016/S1470-2045(20)30540-4. Epub 2020 Nov 27. Lancet Oncol. 2021. PMID: 33253641 Free PMC article. Clinical Trial.
Bladder cancer.
Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, Lotan Y. Sanli O, et al. Among authors: alemozaffar m. Nat Rev Dis Primers. 2017 Apr 13;3:17022. doi: 10.1038/nrdp.2017.22. Nat Rev Dis Primers. 2017. PMID: 28406148 Free article. Review.
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor.
Prokhnevska N, Cardenas MA, Valanparambil RM, Sobierajska E, Barwick BG, Jansen C, Reyes Moon A, Gregorova P, delBalzo L, Greenwald R, Bilen MA, Alemozaffar M, Joshi S, Cimmino C, Larsen C, Master V, Sanda M, Kissick H. Prokhnevska N, et al. Among authors: alemozaffar m. Immunity. 2023 Jan 10;56(1):107-124.e5. doi: 10.1016/j.immuni.2022.12.002. Epub 2022 Dec 28. Immunity. 2023. PMID: 36580918 Free PMC article.
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.
Jansen CS, Prokhnevska N, Master VA, Sanda MG, Carlisle JW, Bilen MA, Cardenas M, Wilkinson S, Lake R, Sowalsky AG, Valanparambil RM, Hudson WH, McGuire D, Melnick K, Khan AI, Kim K, Chang YM, Kim A, Filson CP, Alemozaffar M, Osunkoya AO, Mullane P, Ellis C, Akondy R, Im SJ, Kamphorst AO, Reyes A, Liu Y, Kissick H. Jansen CS, et al. Among authors: alemozaffar m. Nature. 2019 Dec;576(7787):465-470. doi: 10.1038/s41586-019-1836-5. Epub 2019 Dec 11. Nature. 2019. PMID: 31827286 Free PMC article.
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
Daneshmand S, Cary C, Masterson T, Einhorn L, Adra N, Boorjian SA, Kollmannsberger C, Schuckman A, So A, Black P, Bagrodia A, Skinner E, Alemozaffar M, Brand T, Eggener S, Pierorazio P, Stratton K, Nappi L, Nichols C, Luo C, Li M, Hu B. Daneshmand S, et al. Among authors: alemozaffar m. J Clin Oncol. 2023 Jun 1;41(16):3009-3018. doi: 10.1200/JCO.22.00624. Epub 2023 Mar 13. J Clin Oncol. 2023. PMID: 36913642 Clinical Trial.
Editorial Commentary.
Alemozaffar M. Alemozaffar M. Urol Pract. 2017 Sep;4(5):394. doi: 10.1016/j.urpr.2016.09.021. Epub 2017 Jun 28. Urol Pract. 2017. PMID: 37300121 No abstract available.
C-reactive protein in urologic cancers.
Huang J, Baum Y, Alemozaffar M, Ogan K, Harris W, Kucuk O, Master VA. Huang J, et al. Among authors: alemozaffar m. Mol Aspects Med. 2015 Nov;45:28-36. doi: 10.1016/j.mam.2015.04.001. Epub 2015 Apr 29. Mol Aspects Med. 2015. PMID: 25936279 Review.
Author Reply.
Broggi MS, Patil D, Baum Y, Nieh PT, Alemozaffar M, Pattaras JG, Ogan K, Master VA. Broggi MS, et al. Among authors: alemozaffar m. Urology. 2016 Oct;96:105. doi: 10.1016/j.urology.2016.05.066. Epub 2016 Aug 15. Urology. 2016. PMID: 27539917 No abstract available.
Surgery for high-risk prostate cancer and metastatic prostate cancer.
Safir IJ, Lian F, Alemozaffar M, Master VA. Safir IJ, et al. Among authors: alemozaffar m. Curr Probl Cancer. 2015 Jan-Feb;39(1):33-40. doi: 10.1016/j.currproblcancer.2014.11.006. Epub 2014 Nov 25. Curr Probl Cancer. 2015. PMID: 25557291 Review. No abstract available.
54 results